ESC Prevention of CVD Programme: Acknowledgements
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
ACVC Clinical Decision-Making Toolkit

One of the best tools to help practitioners make the best bedside clinical decisions when managing patients with acute cardiovascular disease.

See more
Be Guidelines Smart

A comprehensive guidelines implementation toolkit especially for Nurses & Allied Professionals. 

See more

Project Management Group

  • Nicolle Kränkel (EAPC)-  Project Leader
  • Marco Guazzi (EAPC) - Deputy Project Leader
  • Maddalena Lettino (ACVC) - Coordinator
  • Susanna Price (ACVC) - Deputy Coordinator
  • Catriona Jennings (ACNAP) - Coordinator
  • Donna Fitzsimons (ACNAP) - Deputy Coordinator

Phase III: Continued Roll-out, Evaluation and Follow-up

Work Package Coordinators and Contributors (2018-2019)

Work Package 1: Awareness

Coordinators

  • Konstantin Krychtiuk
  • Silvia Castelletti

Contributors

  • Paul Dendale (EAPC)
  • Mary Kerins (ACNAP)
  • Ines Frederix (EAPC)
  • Flavio D'Ascenzi (EAPC)
Work Package 2: Setting Standards / Audit

Coordinator

  • Arno Hoes

Contributors

  • Kasia Czerwinska (ACVC)
  • Anna Oleksiak (ACVC)
  • Izabella Uchmanowicz (ACNAP)
  • Gabrielle McKee (ACNAP)
  • Margrét Hrönn Svavarsdóttir (ACNAP)
  • Advisor: Ian Graham
Work Package 3 : Implementation Tools

Coordinator

  • Arne Janssen

Contributors

  • Xavier Rossello (ACVC)
  • Ekaterini Lambrinou (ACNAP)
  • Advisors: Jannick Dorresteijn / Frank Visseren

Phase II: Focus on Secondary Prevention (January 2016 - June 2017)

Work Package Coordinators and Contributors

Webinars & online education
  • Lale Tokgozoglu (EAPC) - Coordinator
  • Ingo Ahrens (ACVC)
  • Eleni Kletsiou (ACNAP)
Masterclasses
  • Jean-Paul Schmid (EAPC) - Coordinator 
  • Kurt Huber (ACVC)
  • Gabrielle McKee (ACNAP)
Web
  • Paul Dendale (EAPC) - Coordinator
  • Konstantin Krychtiuk (ACVC)
  • Mary Kerins (ACNAP)
Scientific resources
  • Massimo Piepoli (EAPC) - Coordinator
  • David Walker (ACVC)
  • Donna Fitzsimons (ACNAP)
Patient survey
  • Catriona Jennings (ACNAP) - Coordinator
  • Eva Prescott (EAPC)
  • Chris Gale (ACVC)
  • Felicity Astin & Tina Hansen (ACNAP)
EJPC Supplement
  • Diederick Grobbee (EAPC) - EJPC Editor in Chief & Coordinator
  • Marco Guazzi (EAPC) - Guest Editor
  • Christiaan Vrints (ACVC) - Guest Editor
  • Ekaterini Lambrinou (ACNAP) - Guest Editor
National CVD Prevention Coordinators workshop
  • Arno Hoes (EAPC) - Coordinator
  • Sergio Leonardi (ACVC)
  • Catriona Jennings (ACNAP)

Phase I: Secondary Prevention after Myocardial Infarction (2015)

Web Work Package Group

  • Paul Dendale - Jessa Hospital, Hasselt, Belgium
  • Konstantin Krychtiuk - Medical University of Vienna, Vienna, Austria
  • Mary Kerins - St James's Hospital, Dublin 8
  • Ines Frederix (Global reviewer): (1) Jessa Hospital, Department of Cardiology, Hasselt, Belgium
    (2) Hasselt University, Faculty of Medicine & Life Sciences, Hasselt, Belgium
    (3) Antwerp University, Faculty of Medicine & Health Sciences, Antwerp, Belgium 

IHD in your country

First author
  • Lene Rørholm Pedersen - University Hospital of Sealand, Roskilde, Denmark
  • Eva Prescott - Professor, Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark
Reviewer
  • Mary Kerins - St James's Hospital, Dublin 8

Risk assessment

First author
  • Visseren FL - University Medical Center Utrecht, The Netherlands
  • J Dorresteijn - University Medical Center Utrecht, The Netherlands
Reviewer
  • Gabrielle Mckee - School of Nursing & Midwifery Trinity College Dublin

How to approach your patient

First author
  • Izabella Uchmanowicz - Wroclaw Medical University, Poland
Reviewer
  • Ugo Corra - Istituti Clinici Salvatore Maugeri, Veruno, Italy

Treatment goals

First author
  • Massimo Piepoli - Cardiology, Guglielmo da Saliceto Hospital, Piacenza, Italy
Reviewer
  • Jeroen Hendriks - Centre for Heart Rhythm Disorders, University of Adelaide, South Australian Health and Medical Research Institute and Royal Adelaide Hospital, Australia

Cardioprotective drugs - antiplatelets

First author
  • Pascal Vranckx - Heart Center Hasselt, Hasselt, Belgium
Reviewer
  • Kurt Huber - Wilhelminen Hospital Vienna, Vienna, Austria

Cardioprotective drugs - ACE-I / ARBS

First author
  • Héctor Bueno - Hospital Universitario 12 de Octubre, Madrid, Spain
  • Roberto Martin Asenjo - Hospital Universitario 12 de Octubre, Madrid, Spai
Reviewer
  • Michael Mcintosh - University of Sheffield, United Kingdom

Cardioprotective drugs - beta-blocker

First author
  • Ines Frederix: (1) Jessa Hospital, Department of Cardiology, Hasselt, Belgium
    (2) Hasselt University, Faculty of Medicine & Life Sciences, Hasselt, Belgium
    (3) Antwerp University, Faculty of Medicine & Health Sciences, Antwerp, Belgium
Reviewer
  • Michael Macintosh - University of Sheffield, United Kingdom

Cardioprotective drugs - statins

First author
  • Konstantin Krychtiuk - Medical University of Vienna, Vienna, Austria
Reviewer
  • Walter S. Speidl - Medical University of Vienna, Vienna, Austria

Cardioprotective drugs - polypills

First author
  • Diederick E. Grobbee - Julius Center for Health Sciences and Primary Care, Clinical Epidemiology, University Medical Center Utrecht, Netherlands

Risk factor control - blood pressure

First author
  • Guy De Backer - Department of Cardiology, Ghent University Hospital, Ghent, Belgium
  • Tine De Backer - Department of Cardiology, Ghent University Hospital, Ghent, Belgium
Reviewer
  • Christiaan Vrints - Department of Cardiology, Antwerp University, Antwerp, Belgium

Risk factor control - lipids

First author
  • Olov Wiklund Wallenberg - Laboratory, Sahlgrenska University Hospital, Göteborg, Sweden
Reviewer
  • Ana Abreu - Hospital Santa Marta, CHLC, Lisbon, Portugal

Risk factor control - glycemic

First author
  • Josef Niebauer - Institute of Sports Medicine of the State of Salzburg, Salzburg, Austria
Reviewer
  • Paul Dendale - Jessa Hospital, Hasselt, Belgium

Risk factor control - weight

First author
  • Gabriele Riccardi Federico - II University, Naples, Italy
Reviewer
  • Paul Dendale - Jessa Hospital, Hasselt, Belgium

Risk factor control - smoking

First author
  • Vassilis Vassiliou - Norwich Medical School and Imperial College London, UK
Reviewer
  • Paul Dendale - Jessa Hospital, Hasselt, Belgium

Risk factor control - nutrition

First author
  • Claire Kerins - School of Health Sciences, National University of Ireland Galway, University Road, Galway, Ireland.
Reviewer
  • Demosthenes B. Panagiotakos - School of Health Science & Education, Harokopio University, Athens - Kalithea, Greece

Risk factor control - physical exercise

First author
  • Dominique Hansen - Hasselt University - Campus, Diepenbeek, Belgium
Reviewer
  • Paul Dendale - Jessa Hospital, Hasselt, Belgium

Cardiac rehabilitation and exercise training recommendations

First author
  • Maria Back - Institute and the Medical and Health Sciences, Linkoping, Sweden
  • Tina Hansen - Zealand University Hospital, Department of Cardiology, Denmark
Reviewer
  • Ines Frederix: (1) Jessa Hospital, Department of Cardiology, Hasselt, Belgium
    (2) Hasselt University, Faculty of Medicine & Life Sciences, Hasselt, Belgium
    (3) Antwerp University, Faculty of Medicine & Health Sciences, Antwerp, Belgium

The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer for good, and Sanofi and Regeneron in the form of educational grants.